Friday, July 1, 2016

AstraZeneca sells two dermatology drug rights to LEO Pharma

July 1 (Reuters) - British drugmaker AstraZeneca Plc

said it sold the rights to develop an experimental mid-stage

drug to treat atopic dermatitis to privately-held LEO Pharma.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)